a double-blind , crossover study was designed to compare the safety and efficacy of mexiletine with that of placebo in reducing premature ventricular complexes ( pvc ) in ambulatory patients and to find out the dose which gives a good therapeutic response with a minimal incidence of side-effects .
C0025887
mexiletine
C0151636
premature ventricular complexes